December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.170 -0.580 (-5.95%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
65 66 Next >
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment ↗
These are the short-squeeze stocks to buy as they represent oversold names with positive impending catalysts. 
Via InvestorPlace
News headline image
(NVAX) - Analyzing Novavax's Short Interest ↗
 
Via Benzinga
News headline image
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial Company' ↗
Jim Cramer can't recommend Twilio due to recent stock downgrade. He prefers Vistra Corp. and Constellation Energy Corp. for energy market. 
Via Benzinga
News headline image
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Is It Too Late to Buy Novavax Stock? ↗
Shares of the vaccine maker are trading up 230% this year. 
Via The Motley Fool
GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC
Via AB Newswire
News headline image
3 Penny Stocks Set to Surge 500% by 2026: June Edition ↗
These are the undervalued penny stocks to buy as they represent emerging companies with potential for robust growth and cash flow upside 
Via InvestorPlace
News headline image
Top 4 Large-Cap Stocks With Major Short Interest
As meme stock mania continues, stocks with high short interest like Novavax, Upstart, C3.ai, and Comstock Resources may attract renewed interest. 
Via MarketBeat
Spotlight June 2024: NASDAQ Stocks Under $2 Achieving Major Milestones TELL, DYAI, PRSO, SPEC, GME
Via AB Newswire
Topics Energy
News headline image
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants ↗
After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio. 
Via InvestorPlace
News headline image
Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗
These pharma and biotech players could become long-term winners. 
Via The Motley Fool
News headline image
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? ↗
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga
News headline image
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In May: Where Do Nvidia, Tesla, GameStop, AMC Rank? ↗
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
News headline image
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season ↗
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1. 
Via Benzinga
News headline image
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar ↗
These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials. 
Via InvestorPlace
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
Via AB Newswire
News headline image
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map ↗
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month. 
Via Benzinga
News headline image
Novavax Stock’s Recent Surge and Future Potential
Novavax's future hinges on its ability to translate recent stock market momentum into sustained financial performance. 
Via MarketBeat
Topics Economy
News headline image
Novavax Stock Soars On FDA COVID-19 Update: Fundamental Rally Or Potential Short Squeeze? ↗
Novavax (NASDAQ: NVAX) stock surges on positive COVID-19 vaccine news, with FDA setting a PDUFA review date for April 2025. High trading volume and strong technical indicators make it a compelling... 
Via Benzinga
News headline image
Are Institutional Investors Giving Up on Cava (CAVA) Stock? ↗
Cava stock is down on Thursday as traders worry that an institutional investor is giving up on the company after a share sale. 
Via InvestorPlace
News headline image
What's Going On With Novavax Stock Thursday? ↗
The FDA's committee of independent advisors voted unanimously on Wednesday to recommend that the FDA tell vaccine makers to update their COVID-19 shots to make them more effective against the JN.1... 
Via Benzinga
News headline image
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock? ↗
Novavax will be ready for the new Covid-19 JN.1 variants in September, but NVAX stock is also undergoing a short squeeze. 
Via InvestorPlace
News headline image
Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move ↗
Novavax also said it's planning to launch a JN.1-focused Covid booster shot this fall. 
Via Investor's Business Daily
News headline image
Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September ↗
The company also mentioned that it anticipates commercial delivery of the protein-based vaccine in the U.S. in September, pending authorization. The 
Via Benzinga
Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns
Via AB Newswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
65 66 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.